← Leaderboards
Jessica Nichole Spradlin
University Of California Berkeley
$111,682
Attributed
$111,682
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $71.2K · FY2019–20$100K$75K$50K$25K$0
'19
'20
Funding mix
By agency
NIH$111,682 · 2
By mechanism
F31$68,558 · 1
F99$43,124 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- Christopher J. Chang$14,809,095
- Roberto Zoncu$9,430,559
- Carl Ward$506,122
- Jasper D Rine$24,812,020
- Jay D Keasling$3,063,462
Others in their field
Other Emerging Leaders on “Proteome”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$52,650,525
- Leonard Freedman · Leidos Biomedical Research, Inc.$40,885,615
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Kathleen Maletic Neuzil · Emory University$26,552,931
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Leonard Freedmand · Leidos Biomedical Research, Inc.$25,294,913
Research focus
ProteomeCancer TherapyMalignant NeoplasmsProteinsTechnologyUbiquitin-Protein LigaseInterestLigandsModalityProtein DegradationRecruitScreeningBaseChemoproteomicsBindingInhibitor/AntagonistActivity-Based Protein ProfilingLibrariesCysteineAntineoplastic AgentsDrug DiscoveryNatural ProductsCell TypeCancer Type
Grant awards (3)
Using chemoproteomic approaches to expand upon induced-proximity modalities for cancer therapy$43,124
F99 · FY2020 · CA · contact PI
Targeting RNF114 for Cancer Therapy and Targeted Protein Degradation$28,075
F31 · FY2020 · CA · contact PI
Targeting RNF114 for Cancer Therapy and Targeted Protein Degradation$40,483
F31 · FY2019 · CA · contact PI